首页> 外文OA文献 >Effects of a Low-oestrogen Oral Contraceptive on Urinary Excretion of Luteinizing Hormone and Ovarian Steroids
【2h】

Effects of a Low-oestrogen Oral Contraceptive on Urinary Excretion of Luteinizing Hormone and Ovarian Steroids

机译:低雌激素口服避孕药对黄体激素和卵巢类固醇尿排泄的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The urinary gonadotrophin and ovarian steroid excretion pattern was studied in five women taking an oral contraceptive formulation consisting of mestranol 50 μg and norethisterone 1 mg. Both the pretreatment and post-treatment cycles were normal. The ovulatory peak of luteinizing hormone (LH) during the treatment cycles was uniformly suppressed, but LH continued to be excreted within the normal range. In one fifth of the treatment cycles there was a pronounced and sustained rise of oestrogen output in the absence of ovulation, and in many of the other treatment cycles oestrogen levels suggested that active ovarian steroidogenesis was taking place.
机译:在五名服用口服避孕药的妇女中研究了尿促性腺激素和卵巢类固醇的排泄方式,其中口服避孕药的量为50μg的雌三醇和1 mg的炔诺酮。治疗前和治疗后周期均正常。黄体生成激素(LH)在治疗周期中的排卵高峰被均匀抑制,但LH继续在正常范围内排泄。在五分之一的治疗周期中,在没有排卵的情况下,雌激素的输出持续显着增加,在许多其他治疗周期中,雌激素水平表明正在发生活跃的卵巢类固醇生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号